Skip to main content

Advertisement

Table 1 Baseline demographic data of subjects with and without cardiac or metabolic syndrome X

From: Circulating adipokines and insulin resistance in subjects with combined cardiac and metabolic syndrome X

  CSX (−) MetX (−) (N = 39) CSX (+) MetX (−) (N = 35) CSX (−) MetX (+) (N = 15) CSX (+) MetX (+) (N = 24) p a p b
Gender (M/F) 25/14 25/10 8/7 14/10 0.593  
Age (years) 59 (49, 68) 56 (50, 65) 54 (46, 61) 55 (50, 66) 0.638 0.655
Hypertension (N) (%) 8 (20.5 %) 15 (42.9 %) 9 (60 %) 22 (91.7 %) <0.001  
Body mass index (kg/m2) 23.8 (22.4, 26.0) 25.2 (23.9, 27.6) 28.6 (25.5, 31.5) 27.7 (24.6, 30.8) <0.001 <0.001
Current smoking (N) (%) 2 (5.1 %) 6 (17.1 %) 4 (26.7 %) 9 (37.5 %) 0.012  
Total cholesterol (mg/dL) 151 (134, 170) 164 (146, 193) 166 (135, 196) 185 (159, 211) 0.004 <0.001
Calculated LDL-C (mg/dL) 83 (74, 104) 96 (83, 120) 93 (67, 106) 97 (76, 134) 0.105 0.057
HDL-C (mg/dL) 48 (41, 60) 51 (46, 56) 42 (36, 44) 43 (38, 48) <0.001 0.015
Triglycerides (mg/dL) 86 (51, 115) 83 (64, 113) 156 (116, 192) 203 (145, 240) <0.001 <0.001
Fasting plasma glucose (mg/dL) 94 (88, 112) 95 (89, 113) 110 (102, 126) 106 (93, 128) 0.012 0.015
Fasting serum insulin (µIU/mL) 4.5 (2.9, 9.9) 8.4 (4.9, 10.6) 9.2 (5.9, 16.7) 9.4 (5.1, 19.9) 0.022 0.012
Hs-CRP (mg/dL) 0.127 (0.057, 0.344) 0.079 (0.036, 0.297) 0.220 (0.152, 0.530) 0.138 (0.082, 0.318) 0.180 0.661
Medication use
 Use of statin (N) (%) 3 (7.7 %) 2 (5.7 %) 0 3 (12.5 %) 0.506  
 Use of ACEI or ARB (N) (%) 12 (30.8 %) 7 (20 %) 3 (20 %) 10 (41.7 %) 0.270  
  1. Data are expressed as median (interquartile range, 25th percentile to 75th percentile) because of a non-normal distribution
  2. ACEI angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers, CSX cardiac syndrome X, HDL-C high-density lipoprotein cholesterol, Hs-CRP high sensitivity C-reactive protein, LDL-C low-density lipoprotein cholesterol, MetX metabolic syndrome X, Statin HMG-CoA reductase inhibitors
  3. ap value for Kruskal–Wallis test among the four groups
  4. bp value Mann–Whitney U test for CSX (+) and MetX (+) vs. CSX (−) and MetX (−)
  5. Mann–Whitney U test, Bonferroni corrected p cut-off value for significance <0.0083